Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000226194 | SCV000289895 | benign | Arrhythmogenic right ventricular dysplasia 13 | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651092 | SCV001863663 | benign | not provided | 2018-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002450700 | SCV002740156 | likely benign | Inborn genetic diseases | 2022-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001699166 | SCV003928373 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001699166 | SCV001924171 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699166 | SCV001959206 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001699166 | SCV001973588 | benign | not specified | no assertion criteria provided | clinical testing |